MedTrace Logo

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin

NCT02438397 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-05-08

No results posted yet for this study

Summary

the study objective: to explore the efficacy of acarbose and metformin on glucose fluctuations as add on therapy in type 2 diabetes patients inadequately controlled with premix insulin.

Conditions

Interventions

DRUG

premix insulin

Premix-insulin(human insulin or analog) treatment will continue

DRUG

metformin

500 mg tid by Merck

DRUG

Acarbose

100mg tid by Bayer

Sponsors & Collaborators

  • Shanghai 6th People's Hospital

    lead OTHER

Principal Investigators

  • Weiping Jia, doctor · the 6th affiliated hospital of Shanghai Jiaotong university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438397 on ClinicalTrials.gov